Origami Therapeutics

origamitherapeutics.com

Origami Therapeutics is a preclinical-stage biopharmaceutical company focused on developing innovative protein degrader therapeutics for neurodegenerative diseases such as Huntington's, Alzheimer's, and Parkinson's. Utilizing their proprietary ORICISION™ Drug Discovery Platform, they aim to selectively degrade disease-causing proteins while sparing normal proteins, addressing the challenge of 'undruggable' targets. Their approach leverages the body's natural protein disposal system, promising a new class of treatments that could significantly improve patient outcomes in a market with high unmet needs. With a strong leadership team and a commitment to groundbreaking research, Origami is positioned to make a substantial impact in the field of neurodegenerative disease treatment.